AQUILUS PHARMACEUTICALS INC
Biotech · Private
A selective dual MMP-2/MMP-9 inhibitor small molecule (AQU-118) for treating amyotrophic lateral sclerosis
- Grants
- $4.6M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of a MMP Inhibitor for Neuropathic Pain | $556,249 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a MMP Inhibitor for Neuropathic Pain | $1,931,422 | |
| Federal grant | Department of Health and Human Services · Phase I · Orally active MMP inhibitor for the treatment of bone cancer pain | $287,199 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a MMP Inhibitor for Neuropathic Pain | $1,375,173 | |
| Federal grant | Department of Health and Human Services · Phase I · Matrix Metalloproteinase-2/-9 Inhibitor For The Treatment Of ALS | $457,639 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3016 | DeepMind | — | — |
| 3017 | MAA Laboratories Inc. | — | — |
| 3018 | GLYCOMANTRA INC | — | — |
| 3019 | AQUILUS PHARMACEUTICALS INC | — | — |
| 3020 | Dualogics LLC | — | — |
| 3021 | Deep Cell Industries Inc. | — | $771K |
| 3022 | Nitrase Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compounds And Methods For The Treatment Of Degenerative Disordersgranted
- Compounds And Methods For The Treatment Of Degenerative Disordersapplication
- Compounds And Methods For The Treatment Of Degenerative Disordersapplication
- Matrix Metalloproteinase Inhibitors And Methods For The Treatment Of Pain And Other Diseasesapplication
- Compounds And Methods For The Treatment Of Pain And Other Diseasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.